Literature DB >> 14708023

Challenges of implementing pharmacogenetics in the critical care environment.

Bradley D Freeman1, Howard L McLeod.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14708023     DOI： 10.1038/nrd1285

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

1.  Considerations in the construction of an instrument to assess attitudes regarding critical illness gene variation research.

Authors:  Bradley D Freeman; Carie R Kennedy; Dragana Bolcic-Jankovic; Alexander Eastman; Ellen Iverson; Erica Shehane; Aaron Celious; Jennifer Barillas; Brian Clarridge
Journal:  J Empir Res Hum Res Ethics       Date:  2012-02       Impact factor: 1.742

2.  Profiling genes in the ICU: are we there yet?

Authors:  Jérôme Pugin
Journal:  Intensive Care Med       Date:  2008-04-05       Impact factor: 17.440

3.  Surrogate receptivity to participation in critical illness genetic research: aligning research oversight and stakeholder concerns.

Authors:  Bradley D Freeman; Kevin Butler; Dragana Bolcic-Jankovic; Brian R Clarridge; Carie R Kennedy; Jessica LeBlanc; Sara Chandros Hull
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

4.  Ethical considerations in the collection of genetic data from critically ill patients: what do published studies reveal about potential directions for empirical ethics research?

Authors:  B D Freeman; C R Kennedy; H L Frankel; B Clarridge; D Bolcic-Jankovic; E Iverson; E Shehane; A Celious; B A Zehnbauer; T G Buchman
Journal:  Pharmacogenomics J       Date:  2009-12-08       Impact factor: 3.550

5.  Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients.

Authors:  Bradley D Freeman; David J Dixon; Craig M Coopersmith; Barbara A Zehnbauer; Timothy G Buchman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-10       Impact factor: 2.890
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.